Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Ayala Pharmaceuticals Inc (NQ: AYLA ) N/A UNCHANGED Last Price Updated: 3:56 PM EST, Jan 18, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Ayala Pharmaceuticals Inc < Previous 1 2 3 Next > 12 Health Care Stocks Moving In Tuesday's After-Market Session January 10, 2023 Via Benzinga Stocks That Hit 52-Week Lows On Tuesday January 03, 2023 On Tuesday, 31 stocks hit new 52-week lows. Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session December 27, 2022 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session November 29, 2022 Via Benzinga Recap: Ayala Pharmaceuticals Q3 Earnings November 04, 2022 Ayala Pharmaceuticals (NASDAQ:AYLA) reported its Q3 earnings results on Friday, November 4, 2022 at 08:00 AM. Here's what investors need to know about the announcement. Via Benzinga Stocks That Hit 52-Week Lows On Wednesday October 19, 2022 On Wednesday, 200 companies hit new 52-week lows. Via Benzinga Ayala Pharmaceuticals Presents Poster on AL102 in Desmoid Tumors at the Connective Tissue Oncology Society (CTOS) 2022 Annual Meeting November 17, 2022 From Ayala Pharmaceuticals Via GlobeNewswire Ayala Pharmaceuticals Announces First Patient Dosed with AL102 in Phase 3 Segment of RINGSIDE Trial in Desmoid Tumors November 16, 2022 From Ayala Pharmaceuticals Via GlobeNewswire Ayala Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update November 04, 2022 From Ayala Pharmaceuticals Via GlobeNewswire Stocks That Hit 52-Week Lows On Friday November 11, 2022 On Friday, 63 stocks hit new 52-week lows. Via Benzinga AutoZone To Rise Over 9%? Plus Roth Capital Slashes PT On This Stock By 96% October 20, 2022 Raymond James raised the price target on AutoZone, Inc. (NYSE: AZO) from $2,350 to $2,500. AutoZone shares fell 0.7% to close at $2,289.80 on Wednesday. Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session October 19, 2022 Gainers Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For October 31, 2022 October 31, 2022 Upgrades Via Benzinga Ayala Pharmaceuticals and Advaxis Agree To Combine, Expect Uplisting On NASDAQ October 19, 2022 Ayala Pharmaceuticals Inc (NASDAQ: AYLA) and Advaxis Inc (OTC: ADXS) have announced a merger agreement. Via Benzinga AYLA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Ayala Pharmaceuticals, Inc. Is Fair to Shareholders October 19, 2022 From Halper Sadeh LLC Via Business Wire Benzinga's Top Ratings Upgrades, Downgrades For October 20, 2022 October 20, 2022 Upgrades Via Benzinga Ayala Pharmaceuticals and Advaxis Enter into Merger Agreement October 19, 2022 From Ayala Pharmaceuticals Via GlobeNewswire 12 Health Care Stocks Moving In Monday's Pre-Market Session October 17, 2022 Gainers Acorda Therapeutics (NASDAQ:ACOR) shares increased by 46.1% to $0.49 during Monday's pre-market session. The company's market cap stands at $11.9 million. Via Benzinga Why Olaplex Shares Dipped Around 57%; Here Are 75 Biggest Movers From Yesterday October 20, 2022 Gainers Amprius Technologies, Inc. (NYSE: AMPX) jumped 77.3% to settle at $11.01 on Wednesday after the company announced it was awarded a $50 million cost-sharing grant from the U.S. Department of... Via Benzinga Why United Airlines Shares Are Trading Higher? Here Are 43 Stocks Moving In Wednesday's Mid-Day Session October 19, 2022 Gainers SenesTech, Inc. (NASDAQ: SNES) shares jumped 102.6% to $0.47 after declining over 3% on Tuesday. SenesTech, during August, posted a Q2 loss of $0.21 per share. Via Benzinga Short Volatility Alert: Ayala Pharmaceuticals, Inc. October 03, 2022 On Friday, shares of Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA) experienced volatile short activity. After the activity, the stock price went up +7.00% to $1.00. The overall sentiment for AYLA has been... Via Benzinga Ayala Pharmaceuticals to Host Key Opinion Leader Webinar on Desmoid Tumors September 29, 2022 From Ayala Pharmaceuticals Via GlobeNewswire Why NLS Pharmaceutics Shares Dipped Over 23%; Here Are 67 Biggest Movers From Yesterday September 28, 2022 Gainers Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session September 20, 2022 Via Benzinga Analyzing Ayala Pharmaceuticals's Short Interest September 13, 2022 Ayala Pharmaceuticals's (NASDAQ:AYLA) short percent of float has risen 1512.0% since its last report. The company recently reported that it has 246 thousand shares sold short,... Via Benzinga Why Tuesday Morning Shares Tumbled 31%; Here Are 66 Biggest Movers From Yesterday September 13, 2022 Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) jumped 101.3% to settle at $0.5558 on Monday after the company announced a 1-for-30 reverse stock split. Via Benzinga Why Ventyx Biosciences Is Trading Higher By 70%, Here Are 46 Stocks Moving In Monday's Mid-Day Session September 12, 2022 Gainers Ventyx Biosciences, Inc. (NASDAQ: VTYX) shares jumped 70.4% to $39.37 after Oppenheimer maintained an Outperform rating on the stock and raised its price target from $40 to $65. Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday September 09, 2022 It's time for another deep dive into the biggest pre-market stock movers for Friday and the news that has these shares moving this morning. Via InvestorPlace Why Zumiez Is Trading Lower By 14%; Here Are 20 Stocks Moving Premarket September 09, 2022 Gainers Infobird Co., Ltd (NASDAQ: IFBD) rose 70.8% to $3.16 in pre-market trading after 1:5 reverse stock split takes effect. Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session September 08, 2022 Via Benzinga < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.